A special issue on ‘Cancer’
Tumor suppressor p53 and its gain-of-function mutants in cancer
The regulation of MDM2 oncogene and its impact on human cancers
Role of erbB3 receptors in cancer therapeutic resistance
Regulation of protein stability of DNA methyltransferase 1 by post-translational modifications
Acetylation control of metabolic enzymes in cancer
Hypoxia and cancer cell metabolism
Emerging roles of miR-210 and other non-coding RNAs in the hypoxic response
MicroRNAs and anticancer drugs
Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma